Astrana Health, Inc.
ASTH
$31.81
-$1.44-4.33%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 11.56% | -58.38% | |||
| Total Other Revenue | 5.53% | -6.30% | |||
| Total Revenue | 5.55% | -6.74% | |||
| Cost of Revenue | 5.06% | -10.68% | |||
| Gross Profit | 9.31% | 41.30% | |||
| SG&A Expenses | 19.38% | 2.06% | |||
| Depreciation & Amortization | 0.80% | -15.71% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 6.03% | -9.95% | |||
| Operating Income | -7.50% | 2,954.17% | |||
| Income Before Tax | 75.19% | 606.81% | |||
| Income Tax Expenses | 95.36% | -42.49% | |||
| Earnings from Continuing Operations | 64.22% | 179.99% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -268.37% | -42.98% | |||
| Net Income | 40.81% | 196.27% | |||
| EBIT | -7.50% | 2,954.17% | |||
| EBITDA | -5.53% | 226.01% | |||
| EPS Basic | 38.74% | 192.07% | |||
| Normalized Basic EPS | 29.68% | 1,071.54% | |||
| EPS Diluted | 37.58% | 192.07% | |||
| Normalized Diluted EPS | 29.98% | 1,062.31% | |||
| Average Basic Shares Outstanding | 1.48% | 4.60% | |||
| Average Diluted Shares Outstanding | 1.27% | 5.42% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -0.90% | -- | |||